Webster, TX — HCA Houston Healthcare Clear Lake recently celebrated the completion of their 500th Transcatheter Aortic Valve Replacement (TAVR) procedure.
TAVR has revolutionized the treatment of severe aortic stenosis, a condition characterized by the narrowing of the aortic valve opening, which obstructs the blood flow from the heart to the rest of the body. Patients with aortic valve stenosis may experience shortness of breath, chest pain, fatigue and dizziness, significantly impacting their quality of life. An alternative to open-heart surgery, TAVR is less invasive, allowing patients to recover quickly with an average hospital stay of just one to two days.
“We are proud to have reached this achievement, which showcases our multidisciplinary team,” said Todd Caliva, CEO of HCA Houston Healthcare Clear Lake. “And we are dedicated to providing the Bay Area with exceptional heart and vascular care and remain committed to the care and improvement of human life above all else.”
With the successful completion of the 500th TAVR procedure, HCA Houston Clear Lake demonstrates its commitment to providing nationally recognized care in the prevention, diagnosis, treatment and recovery of cardiovascular diseases. As the only exclusive heart hospital south of the Texas Medical Center, The Heart Hospital at HCA Houston Healthcare Clear Lake offers cardiac catheterization labs, and cardiovascular ICU, along with a comprehensive range of cardiovascular services, including heart and vascular surgery, cardiac emergency care and rehabilitation, advanced imaging, heart screening and imaging. The hospital's commitment to patient-centered care and continuous professional development has earned it widespread recognition and numerous accolades in the field of cardiovascular medicine.
To see if TAVR is right for you, discuss available options and the associated risks with your physician or cardiologist. For general questions, visit the HCA Houston Healthcare Clear Lake webpage.